Login / Signup

Distinguishing myelodysplastic syndromes with moderate-to-severe bone marrow fibrosis from triple-negative primary myelofibrosis based on clinical and genetic covariates.

Junying WuWenjun ZhangPeihong ZhangTiejun QinZefeng XuQi SunYujiao JiaShiqiang QuBing LiHuijun WangLijuan PanJinqin LiuYudi ZhangXin YanRobert Peter GaleZhijian Xiao
Published in: Hematological oncology (2022)
Keyphrases
  • bone marrow
  • mesenchymal stem cells
  • genome wide
  • high intensity
  • copy number